A Clinical Study to undersdtand the effect of Devadarvyadi Vati in the management of Medodushti with special reference to Dyslipidemia.

A Randomized Controlled Clinical Study to assess the effect of Devadarvyadi Vati (Combination of Devadaru,Vacha,Nagara with Guggulu) in the management of Medodushti with special reference to Dyslipidemia. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082328

Enrollment

Registered

2025-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Obese Dyslipidemic and Non-Obese Dyslipidemic Patients (BMI-18.50 to 40.00kg/m2) as per latest Updated WHO Classification of BMI. According to NCEP ATP Classification,the Pilot Project Study by Prevalence in local area and with the guidelines of CCRAS for Dyslipidemia;following are the levels to be selected for said Project. 1) Patient having Serum Total Cholesterol Level 200-239 mg/dl. 2) Patient having Serum LDL Cholesterol Level 130-159 mg/dl. 3) Patient having Serum VLDL Cholesterol Level 40-60 mg/dl. 4) Patient having Serum HDL Cholesterol Level 20-40 mg/dl. 5)Patient having Serum Triglyceride Level 150-190 mg/dl.

Exclusion criteria

Exclusion criteria: 1)Pregnant and Lactating mothers. 2)Patients having Diabetes Mellitus. 3)Patients having history of Respiratory Diseases,Coronary Heart Diseases,Renal Diseases etc. 4)Patients having Acute Complications like Hypertension (BP- 150/90 mm of Hg in those with age 60 and older,and 140/90 mm of Hg for adults less than 60 yrs (According to Eighth Joint National Committee Guideline) 5)Patients having Hepatitis. 6)Patients having disorders like Carcinoma anywhere in the body etc.

Design outcomes

Primary

Measure	Time frame
To study the clinical efficacy of Devadarvyadi Vati(Combination of Devadaru,Vacha,Nagara with Guggulu) in Medodushti with special reference to Dyslipidemia.Timepoint: For 8 weeks	—

Secondary

Measure	Time frame
1)To observe the effect of Devadarvyadi Vati (Combination of Devadaru,Vacha,Nagara with Guggulu) in Lipid Profile over a period of 8 weeks. 2)To compare the effect of Devadarvyadi Vati (Combination of Devadaru,Vacha,Nagara with Guggulu) and Tab.Atorvastatin in Medodushti with special reference to Dyslipidemia.Timepoint: At 4th & 8th week.	—

Countries

India

Contacts

Public ContactDr Bharat Bansi Kadlaskar

R.A.Podar Govt (Ayu) Medical College, Worli,Mumbai-18

drkadlaskar@gmail.com9422330084

Outcome results